WHAT IT IS TRYING TO CHANGE
What the project is doing
NewLimit epigenetic reprogramming is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If it works, this approach could restore healthier behaviour in ageing cells or repair biological damage that the body no longer fixes well on its own.
What has to happen next
The next checkpoint is whether the treatment is safe enough and shows enough biological activity to continue.
What could stop it
The study is mainly about safety and dose. It may not show whether people actually live longer or feel better.